本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Olema Pharmaceuticals, Inc.

10.22
-0.4700-4.40%
盤後8.90-1.3200-12.92%19:59 EDT
成交量:101.33萬
成交額:1,035.28萬
市值:8.91億
市盈率:-4.80
高:10.86
開:10.79
低:10.18
收:10.69
52周最高:36.26
52周最低:6.65
股本:8,715.70萬
流通股本:7,188.81萬
量比:1.27
換手率:1.41%
股息:- -
股息率:- -
每股收益(TTM):-2.1289
每股收益(LYR):-1.8700
淨資產收益率:-52.74%
總資產收益率:-31.82%
市淨率:2.07
市盈率(LYR):-5.47

資料載入中...

2026/08/13

重要事件披露

Form 8-K - Current report
2026/08/10

重要事件披露

Form 8-K - Current report
2026/08/10

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/06

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/30

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/07/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/23

重要事件披露

Form 8-K - Current report
2026/05/26

重要事件披露

Form 8-K - Current report
2026/05/22

重要事件披露

Form 8-K - Current report
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/12

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/12

重要事件披露

Form 8-K - Current report
2026/05/01

重要事件披露

Form 8-K - Current report
2026/04/29

重要事件披露

Form 8-K - Current report
2026/03/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/16

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/03/16

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]